Open AccessThe continuing debate of 5-alpha reductase inhibitors and prostate cancer risk
Author(s) -
Farzana A. Faisal,
Jeffrey J. Tosoian
Publication year - 2018
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.254
H-Index - 30
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr.2018.08.35
Subject(s) - prostate cancer , 5 alpha reductase inhibitor , alpha (finance) , medicine , cancer , prostate , oncology , gynecology , finasteride , surgery , construct validity , patient satisfaction
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom